- Home
- SANG vs ACHV Comparison
SANG vs ACHV Comparison
Compare SANG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- ACHV
- Stock Information
- Founded
- SANG 1984
- ACHV N/A
- Country
- SANG Canada
- ACHV Canada
- Employees
- SANG N/A
- ACHV N/A
- Industry
- SANG Computer Software: Programming Data Processing
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SANG Technology
- ACHV Health Care
- Exchange
- SANG Nasdaq
- ACHV Nasdaq
- Market Cap
- SANG 235.6M
- ACHV 126.9M
- IPO Year
- SANG 2021
- ACHV N/A
- Fundamental
- Price
- SANG $7.01
- ACHV $3.15
- Analyst Decision
- SANG
- ACHV Strong Buy
- Analyst Count
- SANG 0
- ACHV 5
- Target Price
- SANG N/A
- ACHV $14.80
- AVG Volume (30 Days)
- SANG 7.6K
- ACHV 260.4K
- Earning Date
- SANG 02-06-2025
- ACHV 11-07-2024
- Dividend Yield
- SANG N/A
- ACHV N/A
- EPS Growth
- SANG N/A
- ACHV N/A
- EPS
- SANG N/A
- ACHV N/A
- Revenue
- SANG $244,406,000.00
- ACHV N/A
- Revenue This Year
- SANG $3.36
- ACHV N/A
- Revenue Next Year
- SANG $7.39
- ACHV N/A
- P/E Ratio
- SANG N/A
- ACHV N/A
- Revenue Growth
- SANG N/A
- ACHV N/A
- 52 Week Low
- SANG $2.50
- ACHV $3.12
- 52 Week High
- SANG $7.20
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- SANG 57.08
- ACHV 26.85
- Support Level
- SANG $6.89
- ACHV $3.50
- Resistance Level
- SANG $7.15
- ACHV $3.86
- Average True Range (ATR)
- SANG 0.20
- ACHV 0.20
- MACD
- SANG -0.02
- ACHV -0.03
- Stochastic Oscillator
- SANG 51.28
- ACHV 4.05
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.